Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
Advanced search 

    Article Cited by others


Naringenin protects against 1-methyl-4-phenylpyridinium- induced neuroinflammation and resulting reactive oxygen species production in SH-SY5Y cell line: An in Vitro model of parkinson's disease

Mani Sugumar, Sekar Sathiya, Chidambaram Saravana Babu, Sevanan Murugan

Year : 2018| Volume: 14| Issue : 57 | Page no: 458-464

   This article has been cited by
1 Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease
Ahsas Goyal, Aanchal Verma, Nandini Dubey, Jyoti Raghav, Anant Agrawal
Journal of Food Biochemistry. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 The clinical use of curcumin on neurological disorders: An updated systematic review of clinical trials
Maryam Mohseni, Amirhossein Sahebkar, Gholamreza Askari, Thomas P. Johnston, Babak Alikiaii, Mohammad Bagherniya
Phytotherapy Research. 2021;
[Pubmed]  [Google Scholar] [DOI]
3 The Role of Natural Compounds and their Nanocarriers in the Treatment of CNS Inflammation
Bikram Khadka, Jae-Young Lee, Dong Ho Park, Ki-Taek Kim, Jong-Sup Bae
Biomolecules. 2020; 10(10): 1401
[Pubmed]  [Google Scholar] [DOI]


Read this article